Latest Schizoaffective disorder Stories
Results served as basis for regulatory filing with U.S.
TITUSVILLE, N.J., Jan. 19, 2015 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today that the U.S.
Harnisch Productions LLC announces the distribution of Jonathan Harnisch: An Alibiography for review.
Etica Press Ltd announces the release of Jonathan
New submission based on positive data from a 15-month schizoaffective relapse prevention study TITUSVILLE, N.J., May 13, 2014 /PRNewswire/ -- Janssen Pharmaceuticals, Inc., today announced
Demonstrated significant efficacy in manic and depressive mood symptoms and psychosis, and improved patient functioning TITUSVILLE, N.J., May 6, 2014 /PRNewswire/ -- Janssen Pharmaceuticals,
First prospective, randomized clinical trial to reflect context of "real world" issues in treating schizophrenia, including recent incarceration and substance abuse TITUSVILLE, N.J.,
According to a recent research, individuals who have psychotic disorders are using alcohol, tobacco and drugs more when compared to the general population.
New research has found that people diagnosed with a severe psychiatric illness are more likely to smoke tobacco, drink alcohol and use drugs than people without a severe mental condition.